Serum Institute of India (SII) and ICMR on Thursday announced the completion of enrolment process of 1,600 participants in the phase-III clinical trials for COVID-19 vaccine Covishield in the country.
from NDTV News - India-news https://ift.tt/3pk3Gxq
0 Comments